Ultragenyx (RARE) Falls 26% as New Treatment Fails to Get FDA Green Light
Ultragenyx fell by 26.05 percent week-on-week as investor sentiment was largely dragged down by the Food and Drug Administration's (FDA) rejection of its biologics license application (BLA) for its UX111 (ABO-102) treatment.
In a regulatory filing, Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) said that the FDA requested additional information and improvements in relation to certain chemistry, manufacturing, and controls (CMC) aspects.
It noted that the observations were not related to product quality concerns product, adding that many of the issues have already been addressed.
UX111 was developed to treat a common type of Sanfilippo syndrome, a group of genetic conditions that begin in early childhood and causes severe brain damage and early death.
A research team in a laboratory peering through microscopes at a biologic product.
The treatment involves managing symptoms, as there are currently no approved disease-modifying medicines.
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) said it plans to resubmit updated clinical data from current patients after resolving the FDA's concerns. A new review could take another six months upon resubmission of a revised BLA application.
While we acknowledge the potential of RARE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the .
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Cineverse Adds Three Industry Veterans to Accelerate Feature Film Acquisitions and Releasing Business
New Cineverse Motion Pictures Group Brings Key Talent on Board: Steven Peros as VP, Creative Development and Filmmaker Relations; Dan Fisher as VP, Acquisitions; and Cameron Moore as Consultant, Theatrical Distribution LOS ANGELES, July 15, 2025 /PRNewswire/ -- Cineverse (Nasdaq: CNVS), a next-generation entertainment studio, has announced today the addition of three development, acquisitions and distributions experts to the recently-formed Cineverse Motion Pictures Group led by Chief Motion Pictures Officer Yolanda Macias. Effective immediately: Steven Peros is vice president, creative development and filmmaker relations, responsible for both leading development and overseeing physical production, serving as a key connector between the creative community and internal business stakeholders. Peros started in development at New Line Cinema and was the William Morris Agency's top story analyst before becoming a screenwriter, director, producer, playwright, published film historian and graphic novel author, including projects with Disney, Lifetime, Lionsgate, AMC, MTV and NBC. He has taught screenwriting and TV pilot writing at New York Film Academy and UCLA Extension. Dan Fisher is vice president, acquisitions, leading acquisitions for Cineverse's direct-to-digital and OTT slate. Prior to joining Cineverse, he has over a decade of acquisition, digital sales and distribution experience via roles at VMI Worldwide, Freestyle Digital Media, Gravitas Ventures and Entertainment One, and has taught film at universities around the country. Cameron Moore is a consultant for the theatrical distribution business, responsible for directly assisting in strategic planning for theatrical releases, while identifying new film projects to acquire. Moore previously served as senior director, theatrical distribution at Gravitas Ventures, where he oversaw the expansion of his department and contributed to wide releases of films across North America. He has spent his career generating revenues and maximizing profitability, including promotional effectiveness. He has worked at numerous companies including 21st Century Fox, Screenvision Media, and Fathom Events in the United States, in addition to Rogers Media and Alliance Films in Canada. "I'm thrilled to be adding these three talented executives, each with a unique set of skills and experience that will contribute to Cineverse successfully implementing our motion pictures strategy," said Macias. "As we build out our theatrical, digital and streaming slate, we are strongly positioned to identify fandoms to target with IP driven and award winning releases, and reach audiences in an authentic and efficient manner. Our mission is to deliver for fans, creators and partners." About Cineverse Motion Pictures Group Cineverse super-serves passionate audiences by distributing content across all windows and platforms, from theatrical to digital to physical. Following the breakout box office success of Terrifier 3, upcoming releases include the franchise expansions of The Toxic Avenger (August 29, 2025), Silent Night, Deadly Night (December 12, 2025), Return to Silent Hill (January 23, 2026), and Wolf Creek: Legacy (2026) as well as 2025 releases Escape from the 21st Century, Lesbian Space Princess, and The Things You Kill. About Cineverse Cineverse (Nasdaq: CNVS) is a next-generation entertainment studio that empowers creators and entertains fans with a wide breadth of content through the power of technology. It has developed a new blueprint for delivering entertainment experiences to passionate audiences and results for its partners with unprecedented efficiency, and distributes more than 71,000 premium films, series, and podcasts. Cineverse connects fans with bold, authentic, independent stories. Properties include the highest-grossing unrated film in U.S. history; dozens of streaming fandom channels; a premier podcast network; top horror destination Bloody Disgusting; and more. Powering visionary storytelling with cutting-edge innovation, Cineverse's proprietary streaming tools and AI technology drive revenue and reach to redefine the next era of entertainment. For more information, visit Press Contact: For MediaThe Lippin Group, cineverse@ For InvestorsJulie Milstead, investorrelations@ View original content to download multimedia: SOURCE Cineverse Corp. Sign in to access your portfolio
Yahoo
21 minutes ago
- Yahoo
Citigroup (C) Falls More Steeply Than Broader Market: What Investors Need to Know
In the latest trading session, Citigroup (C) closed at $87.60, marking a -1.26% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 0.79% for the day. On the other hand, the Dow registered a loss of 0.94%, and the technology-centric Nasdaq decreased by 0.92%. Heading into today, shares of the U.S. bank had gained 13.37% over the past month, outpacing the Finance sector's gain of 4.61% and the S&P 500's gain of 5.22%. Investors will be eagerly watching for the performance of Citigroup in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on July 15, 2025. The company's earnings per share (EPS) are projected to be $1.67, reflecting a 9.87% increase from the same quarter last year. At the same time, our most recent consensus estimate is projecting a revenue of $20.93 billion, reflecting a 3.92% rise from the equivalent quarter last year. C's full-year Zacks Consensus Estimates are calling for earnings of $7.33 per share and revenue of $83.95 billion. These results would represent year-over-year changes of +23.19% and +3.47%, respectively. Investors should also take note of any recent adjustments to analyst estimates for Citigroup. These recent revisions tend to reflect the evolving nature of short-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential. Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model. The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, there's been a 1% fall in the Zacks Consensus EPS estimate. Right now, Citigroup possesses a Zacks Rank of #3 (Hold). In terms of valuation, Citigroup is currently trading at a Forward P/E ratio of 12.11. This valuation marks a discount compared to its industry average Forward P/E of 16.39. Investors should also note that C has a PEG ratio of 0.69 right now. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. By the end of yesterday's trading, the Financial - Investment Bank industry had an average PEG ratio of 1.37. The Financial - Investment Bank industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 67, placing it within the top 28% of over 250 industries. The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. You can find more information on all of these metrics, and much more, on Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Citigroup Inc. (C) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
21 minutes ago
- Yahoo
Unsung AI stock pops after joining S&P 500
Unsung AI stock pops after joining S&P 500 originally appeared on TheStreet. Though smaller-cap indexes swung wildly, the S&P 500 has been a lot more confident, continuing to grind higher in 2025. Unsurprisingly, Big Tech is pulling its weight, and AI momentum has shown no signs of fading. 💵💰💰💵 That said, one rising AI stock just cleared a massive milestone, and it's quietly stepping onto a bigger stage that will usher in a new growth phase for its business. For companies, getting into the S&P 500 isn't just a flex; it's a monumental event. It's like hitting the jackpot, as you're not only thrown into the spotlight, but also unleashing billions in passive inflows from index funds. Once companies get the green light from the S&P Dow Jones Indices committee, it's game on, as traders, fund managers, and analysts don't wait need a minimum market cap of roughly $22.7 billion, robust liquidity (dollar volume to float above 0.75), and a minimum of 250,000 monthly trading volume. On top of that, companies need at least a 10% public float, a U.S. headquarters, a major exchange listing, and yes, genuine profits in the last quarter and over the past year. An S&P 500 inclusion doesn't just mean a stock bump for companies. It brings more analyst coverage, attractive corporate optics, and even a lower financing structure. In simple terms, the company hits the big leagues, which shows investors that the business has genuine staying power. The index is up 6.6% so far in 2025; it's comfortably outpaced the Dow, while tracking slightly behind the Nasdaq. Generative AI and tech giants are doing all the heavy lifting, but consumer names haven't dropped the ball, either. More Tech Stock News: Veteran analyst drops massive call on AMD stock Bank of America drops shocking call on Super Micro stock Cathie Wood drops bold message on Apple, Tesla stock Despite the inflationary pressures and Fed uncertainty, pullbacks have been mostly shallow. Dips get snapped up quickly by investors who are hunting for value in places such as health care and utilities. Compared to the chaos in smaller-cap names, the S&P's healthy rise feels much more reliable. That's exactly the backdrop one 'sleeper' stock just stepped into. The Trade Desk () just staked its claim to the S&P 500. Trade Desk stock surged 14% on Monday after the digital adtech platform was tapped to join the S&P 500. It replaced ANSYS ahead of its much-talked-about acquisition by Synopsys, with the move becoming official before markets open Friday, July 18. For investors, that upgrade means fresh new capital will be funneling into The Trade Desk, whether markets like it or not. The California-based company operates one of the most advanced AI-powered demand-side platforms (DSPs) in the market. The platform enables advertisers to buy across multiple digital channels, from mobile and desktop to streaming TV in real it gives brands full visibility into where every dollar goes, and users can efficiently target, measure, and optimize campaigns. The real kicker? AI. At the core of its platform is Koa, a tailor-made AI engine that crunches bid signals to predict which ads are likely to perform well. It doesn't just automate bidding — it adapts in real time to efficiently maximize return on investment. And it's not stopping there. The Trade Desk recently launched cutting-edge new tools in tracking viewer behavior across screens, partnering with the leading streaming platforms while rolling out privacy-first identity tech with Unified ID 2.0. What's amazing is that despite the sluggishness in the ad market, The Trade Desk is growing. And now, with its S&P 500 inclusion, it's now finally playing at a tremendous AI stock pops after joining S&P 500 first appeared on TheStreet on Jul 15, 2025 This story was originally reported by TheStreet on Jul 15, 2025, where it first appeared. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
